The Synthetic Melanocortin

In this study, we examined anti-fungal and anti-inflammatory effects of the synthetic melanocortin peptide (Ac-Cys-Lys-Pro-Val-NH.sub.2).sub.2 or (CKPV).sub.2 against Candida albicans vaginitis. Our in vitro results showed that (CKPV).sub.2 dose-dependently inhibited Candida albicans colonies formation. In a rat Candida albicans vaginitis model, (CKPV).sub.2 significantly inhibited vaginal Candida albicans survival and macrophages sub-epithelial mucosa infiltration. For mechanisms study, we observed that (CKPV).sub.2 inhibited macrophages phagocytosis of Candida albicans. Meanwhile, (CKPV).sub.2 administration inhibited macrophage pro-inflammatory cytokines (TNF-[alpha], IL-1[beta] and IL-6) release, while increasing the arginase activity and anti-inflammatory cytokine IL-10 production, suggesting macrophages M1 to M2 polarization. Cyclic AMP (cAMP) production was also induced by (CKPV).sub.2 administration in macrophages. These above effects on macrophages by (CKPV).sub.2 were almost reversed by melanocortin receptor-1(MC1R) siRNA knockdown, indicating the requirement of MC1R in the process. Altogether, our results suggest that (CKPV).sub.2 exerted anti-fungal and anti-inflammatory activities against Candida albicans vaginitis probably through inducing macrophages M1 to M2 polarization and MC1R activation.